Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants.
Main Authors: | Doyle, L, Crowther, C, Middleton, P, Voysey, M, Marret, S, Rouse, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis
by: Crowther, CA, et al.
Published: (2017) -
Antenatal magnesium individual participant data international collaboration: Assessing the benefits for babies using the best level of evidence (AMICABLE)
by: Crowther, C, et al.
Published: (2012) -
Variants of the EAAT2 glutamate transporter gene promoter are associated with cerebral palsy in preterm infants
by: Rajatileka, S, et al.
Published: (2017) -
Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review
by: Linsell, L, et al.
Published: (2016) -
Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT
by: Griffiths, J, et al.
Published: (2018)